+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Endocarditis Drug"

Endocarditis - Pipeline Insight, 2024 - Product Thumbnail Image

Endocarditis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Endocarditis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Endocarditis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Endocarditis is a type of cardiovascular disease caused by an infection of the inner lining of the heart. Endocarditis drugs are used to treat this condition and can be divided into two categories: antibiotics and antifungal medications. Antibiotics are used to treat bacterial infections, while antifungal medications are used to treat fungal infections. These drugs are typically administered intravenously or orally, depending on the severity of the infection. Endocarditis drugs are used to reduce the risk of complications associated with the disease, such as heart valve damage, stroke, and heart failure. They can also help to reduce the risk of recurrence of the infection. Some of the companies in the endocarditis drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. These companies are involved in the development, manufacture, and marketing of endocarditis drugs. Show Less Read more